Environmental, Social And Governance Report

Overview

The report describes Kintor Pharma's 2022 ESG governance, with the Board holding full responsibility and an ESG Working Group supporting implementation. Group-wide Scope 1 and Scope 2 greenhouse gas emissions totaled 4,079.88 ton, while energy consumption was 6,852.6 MWh. The Group also reported no work-related fatalities during the year.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: Ends 31 December 2022
Language: English, Chinese
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services